NEU neuren pharmaceuticals limited

Angelman trial, page-13

  1. 1,484 Posts.
    lightbulb Created with Sketch. 376
    Actually not, Neuren is an invested owner of the Angelman conference and derives income from attendance.

    Current profits from the conference and asosciated merchandise sales are priced in at $3/share - so the more people that attend the conference the better our bottom line.

    Its also possible the Angelman community might go for a passive takeover of Neuren - so its always worth watching the conference discussions to ensure shareholders re informed.

    Hope this helps Snozz !!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
-0.290(1.73%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.58 $16.74 $16.40 $9.107M 549.9K

Buyers (Bids)

No. Vol. Price($)
1 864 $16.43
 

Sellers (Offers)

Price($) Vol. No.
$16.50 1668 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.